RCEL - Avita Medical Ltd - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCEL is currently covered by 4 analysts with an average price target of $9.54. This is a potential upside of $4.64 (94.69%) from yesterday's end of day stock price of $4.9.

Avita Medical Ltd's activity chart (see below) currently has 48 price targets and 51 ratings on display. The stock rating distribution of RCEL is 81.25% BUY and 18.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.62% with an average time for these price targets to be met of 35.57 days.

Highest price target for RCEL is $10, Lowest price target is $3.5, average price target is $7.17.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 17-Feb-2026. First documented stock forecast 31-Dec-2019.

Currently out of the existing stock ratings of RCEL, 13 are a BUY (81.25%), 3 are a HOLD (18.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Dec-2024

$10

$5.25 (110.53%)

$10

21 days ago
(17-Feb-2026)

0/15 (0%)

$5.69 (132.02%)

Hold Since 17-Oct-2025

$3.5

$-1.25 (-26.32%)

$4

1 months 22 days ago
(16-Jan-2026)

1/2 (50%)

$-0.4 (-10.26%)

3

Hold Since 11-Apr-2024

3 months 18 days ago
(20-Nov-2025)

1/3 (33.33%)

$3.57 (23.14%)

87

Buy Since 31-Dec-2019

$8

$3.25 (68.42%)

$14

6 months 27 days ago
(11-Aug-2025)

0/6 (0%)

$3.19 (66.32%)

Buy Since 27-Jun-2023

$21

$16.25 (342.11%)

$21

1 years 2 months 14 days ago
(24-Dec-2024)

0/10 (0%)

$8.09 (62.66%)

Show more analysts

Please expand the browser size to see the chart

What is RCEL (Avita Medical Ltd) average time for price targets to be met?

On average it took 35.57 days on average for the stock forecasts to be realized with a an average price target met ratio 17.62

Which analyst has the current highest performing score on RCEL (Avita Medical Ltd) with a proven track record?

MATT O'BRIEN

Which analyst has the current lower performing score on RCEL (Avita Medical Ltd) with a proven track record?

FRANK TAKKINEN

Which analyst has the most public recommendations on RCEL (Avita Medical Ltd)?

Matt O'brien works at PIPER SANDLER and has 39 price targets and 26 ratings on RCEL

Which analyst is the currently most bullish on RCEL (Avita Medical Ltd)?

Lyanne Harrison with highest potential upside - $16.25

Which analyst is the currently most reserved on RCEL (Avita Medical Ltd)?

Frank Takkinen with lowest potential downside - -$1.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?